相关实验视频

Updated: Sep 16, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

周周血管空间网络和状的预测价值,用于帕金森病中的利沃多巴反应

Zekai Chen¹, Sibo Huang¹, Yuefei Liang¹

¹Department of Radiology, The First Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.

European journal of neurology

|July 11, 2025

概括

较高的胆管 (CP) 体积和自由水 (FW) 分数与帕金森病 (PD) 患者的勒沃多巴反应减少有关. 这些MRI标记可能有助于预测治疗的有效性.

科学领域:

神经成像是一种神经成像.
神经学神经学
生物标志物生物标志物

背景情况:

勒沃多巴反应的个体间变化使帕金森病 (PD) 治疗复杂化.
之前的研究表明,基于MRI的周周血管空间 (PVS) 和胆脉 (CP) 索引和乐伏多巴反应性之间存在联系.

研究的目的:

调查多个MRI指数的关联,包括CP体积,自由水 (FW) 分数,PVS体积分数 (PVSVF) 和PVS (DTI-ALPS) 沿线的扩散张力成像,与PD中的乐伏多巴反应.
为了确定潜在的成像生物标志物来预测勒沃多巴反应.

主要方法:

100名PD参与者的回顾性分析 (54名良好响应者,46名不良响应者) 基于急性勒沃多巴挑战测试.
使用3T核磁共振扫描来计算CP体积,FW分数,PVSVF和DTI-ALPS.
统计分析包括曼-惠特尼U测试和二进制物流回归.

主要成果:

与良好反应者相比,低水平的勒沃多巴反应者表现出明显更高的CP体积和FW分数.
较高的CP体积 (OR,0.986;p=0.038) 和FW分数 (OR,0.883;p<0.01) 独立地与较差的利沃多巴反应相关.
PVSVF和DTI-ALPS没有显示出与勒沃多巴反应的显著关联.

结论:

升高的CP体积和FW分数独立地与帕金森病的勒沃多巴反应性降低有关.
CP体积和FW分数显示为预测利沃多巴治疗结果的成像生物标志物.

关键词:

帕金森病的疾病.冠状动脉 (choroid plexus) 是一个动脉的组成部分.扩散张力成像扩散张力成像磁共振成像技术的使用周围的体空间.

更多相关视频

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.